Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
The New England Journal of Medicine
P A CassilethP H Wiernik
Current Opinion in Hematology
A K Burnett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
R J WellsF Ruymann
Internal Medicine
Jeong Mi LeeGyeong-Won Lee
Journal of Pediatric Hematology/oncology
Katrin ScheinemannOussama Abla